Mouse models of Mdm2 and Mdm4 and their clinical implications

Research output: Contribution to journalReview articlepeer-review

16 Scopus citations

Abstract

Mdm2 and Mdm4 are two key negative regulators of the tumor suppressor p53. Deletion of either Mdm2 or Mdm4 induces p53-dependent early embryonic lethality in knockout mouse models. The tissuespecific deletion of Mdm2 induces p53-dependent apoptosis, whereas the deletion of Mdm4 induces both p53-dependent apoptosis and cell cycle arrest. Compared to Mdm4 deletion, Mdm2 deletion causes more severe phenotypic defects. Disrupting the Mdm2 and Mdm4 interaction using knockin mice models causes embryonic lethality that can be completely rescued by the concomitant loss of p53, suggesting that Mdm2 and Mdm4 heterodimerization is critical to inhibit p53 activity during embryogenesis. Overexpression of Mdm2 and Mdm4 in mice induces spontaneous tumorigenesis, which clearly indicates that Mdm2 and Mdm4 are bona fide oncogenes. Studies from these mouse models strongly suggest that blocking Mdm2- and Mdm4-mediated p53 inhibition is an appealing therapeutic strategy for cancer patients with wild-type p53 alleles.

Original languageEnglish (US)
Pages (from-to)371-375
Number of pages5
JournalChinese Journal of Cancer
Volume32
Issue number7
DOIs
StatePublished - 2013

Keywords

  • Knockin
  • Knockout
  • Mdm2 and Mdm4 inhibitors
  • Transgene
  • p53

ASJC Scopus subject areas

  • Oncology

Fingerprint

Dive into the research topics of 'Mouse models of Mdm2 and Mdm4 and their clinical implications'. Together they form a unique fingerprint.

Cite this